Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giorgio Parmiani

Showing results (21-30 of 105) with videos related to

Pageof 11
Sort By:
Human Vaccines & Immunotherapeutics|December 9, 2014
Peptide-based vaccines for cancer therapyGiorgio Parmiani, Vincenzo Russo, Cristina Maccalli, et al.
Cancer Research|April 6, 2007
Tumor-released microvesicles as vehicles of immunosuppressionRoberta Valenti, Veronica Huber, Manuela Iero, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2014
Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancerZlatko Trajanoski, Cristina Maccalli, Daniele Mennonna, et al.
European Journal of Immunology|July 30, 2003
NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activityCristina Maccalli, Daniela Pende, Chiara Castelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patientsCristina Maccalli, Daisuke Nonaka, Adriano Piris, et al.
Expert Review of Anticancer Therapy|August 24, 2006
Vaccination: role in metastatic melanomaLorenzo Pilla, Roberta Valenti, Andrea Marrari, et al.
Journal of the National Cancer Institute|June 6, 2002
Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?Giorgio Parmiani, Chiara Castelli, Piero Dalerba, et al.
Cellular Signalling|February 16, 2008
PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cellsLuisa Novellino, Annamaria De Filippo, Paola Deho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Interleukin-12: biological properties and clinical applicationMichele Del Vecchio, Emilio Bajetta, Stefania Canova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activationChiara Casati, Chiara Camisaschi, Luisa Novellino, et al.
Pageof 11

Showing results (21-30 of 105) with videos related to

Sort By:
Pageof 11
Human Vaccines & Immunotherapeutics|December 9, 2014
Peptide-based vaccines for cancer therapyGiorgio Parmiani, Vincenzo Russo, Cristina Maccalli, et al.
Cancer Research|April 6, 2007
Tumor-released microvesicles as vehicles of immunosuppressionRoberta Valenti, Veronica Huber, Manuela Iero, et al.
Cancer Immunology, Immunotherapy : CII|August 29, 2014
Somatically mutated tumor antigens in the quest for a more efficacious patient-oriented immunotherapy of cancerZlatko Trajanoski, Cristina Maccalli, Daniele Mennonna, et al.
European Journal of Immunology|July 30, 2003
NKG2D engagement of colorectal cancer-specific T cells strengthens TCR-mediated antigen stimulation and elicits TCR independent anti-tumor activityCristina Maccalli, Daniela Pende, Chiara Castelli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 21, 2007
NKG2D-mediated antitumor activity by tumor-infiltrating lymphocytes and antigen-specific T-cell clones isolated from melanoma patientsCristina Maccalli, Daisuke Nonaka, Adriano Piris, et al.
Expert Review of Anticancer Therapy|August 24, 2006
Vaccination: role in metastatic melanomaLorenzo Pilla, Roberta Valenti, Andrea Marrari, et al.
Journal of the National Cancer Institute|June 6, 2002
Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?Giorgio Parmiani, Chiara Castelli, Piero Dalerba, et al.
Cellular Signalling|February 16, 2008
PTPRK negatively regulates transcriptional activity of wild type and mutated oncogenic beta-catenin and affects membrane distribution of beta-catenin/E-cadherin complexes in cancer cellsLuisa Novellino, Annamaria De Filippo, Paola Deho, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 19, 2007
Interleukin-12: biological properties and clinical applicationMichele Del Vecchio, Emilio Bajetta, Stefania Canova, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 7, 2008
Human lymphocyte activation gene-3 molecules expressed by activated T cells deliver costimulation signal for dendritic cell activationChiara Casati, Chiara Camisaschi, Luisa Novellino, et al.
Pageof 11